Atlas Trials

Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

Clinical trial NCT00425165 · TERMINATED

Trial details

NCT number
NCT00425165
Sponsor
Merck Sharp & Dohme LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2007-08-01
Primary completion
2008-05-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.